FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshio Fujioka

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Phenomena

Blotting, Northern

Concepts & Ideas

Circadian Rhythm

Co-author Network

Publications

TOP 3
Yutaka Takahashi; Keiji Iida; Ryoko Takeno; Riko Kitazawa; Sohei Kitazawa; Hidetsuna Kitamura; Yoshio Fujioka; Hiroyuki Yamada; Fumio Kanda; Shigeo Ohta; Kiyomi Nishimaki; Masayo Fujimoto; Takeshi Kondo; Genzo Iguchi; Kentaro Takahashi; Hidesuke Kaji; Yasuhiko Okimura; Kazuo Chihara
Hepatic failure and enhanced oxidative stress in mitochondrial diabetes.
Hirokuni Akahori; Takeshi Tsujino; Motomaru Masutani; Takafumi Akagami; Keiji Tanabe; Miho Masai; Yoshio Fujioka; Mitsumasa Ohyanagi; Tohru Masuyama
[Postgastrectomy beriberi exaggerated by diuretic use: a case report].
Hiroshi Okamoto; Yoshio Fujioka; Akihiro Takahashi; Tomosaburo Takahashi; Takahiro Taniguchi; Yuichi Ishikawa; Mitsuhiro Yokoyama
Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshio Fujioka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Yutaka Takahashi; Keiji Iida; Ryoko Takeno; Riko Kitazawa; Sohei Kitazawa; Hidetsuna Kitamura; Yoshio Fujioka; Hiroyuki Yamada; Fumio Kanda; Shigeo Ohta; Kiyomi Nishimaki; Masayo Fujimoto; Takeshi Kondo; Genzo Iguchi; Kentaro Takahashi; Hidesuke Kaji; Yasuhiko Okimura; Kazuo Chihara
Hepatic failure and enhanced oxidative stress in mitochondrial diabetes.
Endocrine journal 2008;55(3):509-14.
2007: Hirokuni Akahori; Takeshi Tsujino; Motomaru Masutani; Takafumi Akagami; Keiji Tanabe; Miho Masai; Yoshio Fujioka; Mitsumasa Ohyanagi; Tohru Masuyama
[Postgastrectomy beriberi exaggerated by diuretic use: a case report].
Journal of cardiology 2007;49(1):49-53.
2006: Hiroshi Okamoto; Yoshio Fujioka; Akihiro Takahashi; Tomosaburo Takahashi; Takahiro Taniguchi; Yuichi Ishikawa; Mitsuhiro Yokoyama
Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1).
Journal of atherosclerosis and thrombosis 2006;13(4):183-91.
2006: Kohei Kamemura; Yoshio Fujioka; Hiroshi Takaishi; Akihiro Takahashi; Takahiro Taniguchi; Yuichi Ishikawa; Mitsuhiro Yokoyama
Chylomicron remnants upregulate CD40 expression via the ERK pathway and a redox-sensitive mechanism in THP-1 cells.
Atherosclerosis 2006;187(2):257-64.
2006: Kozo Ninomiya; Akihiro Takahashi; Yoshio Fujioka; Yuichi Ishikawa; Mitsuhiro Yokoyama
Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells.
Hypertension research : official journal of the Japanese Society of Hypertension 2006;29(4):269-76.
2006: Takahiro Okumura; Yoshio Fujioka; Shinji Morimoto; Miho Masai; Tsuyoshi Sakoda; Takeshi Tsujino; Shin-ichiro Kashiwamura; Haruki Okamura; Mitsumasa Ohyanagi
Chylomicron remnants stimulate release of interleukin-1beta by THP-1 cells.
Journal of atherosclerosis and thrombosis 2006;13(1):38-45.
2005: Yuko Takahashi; Yoshio Fujioka; Tomosaburo Takahashi; Koji Domoto; Akihiro Takahashi; Takahiro Taniguchi; Yuichi Ishikawa; Mitsuhiro Yokoyama
Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells.
Life sciences 2005;77(6):670-82.
2005: Shinji Morimoto; Yoshio Fujioka; Chikako Tsutsumi; Miho Masai; Takahiro Okumura; Masao Yuba; Tsuyoshi Sakoda; Takeshi Tsujino; Mitsumasa Ohyanagi
Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
The American journal of the medical sciences 2005;329(4):211-3.
2005: Takeshi Tsujino; Yoshiro Naito; Daizo Kawasaki; Satoshi Okuda; Tsuyoshi Sakoda; Yoshio Fujioka; takeshi sugaya; Mitsumasa Ohyanagi
Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2005;27(2-3):159-68.
2005: Yoshio Fujioka; Mitsuhiro Yokoyama
[Magnesium, cardiovascular risk factors and atherosclerosis].
Clinical calcium 2005;15(2):221-5.
2004: Takatoshi Sakaki; Yoshio Fujioka; Takafumi Akagami; Miho Masai; Hiroshi Shimizu; Tsuyoshi Sakoda; Takeshi Tsujino; Mitsumasa Ohyanagi
Cardiac wall motion abnormalities observed in a patient with transient hyperthyroidism.
Japanese heart journal 2004;45(6):1071-7.
2004: Yoshio Fujioka; Takahiro Taniguchi; Mitsuhiro Yokoyama; Yuichi Ishikawa
[Inhibitory effect of nitric oxide on oxidation of low-density lipoprotein].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 9():493-5.
2004: Kazumi Tonomo; Takeshi Tsujino; Yoshio Fujioka; Shinji Nakao; Hideki Yao; Hitoshi Yasoshima; Akira Kubota; Tadaaki Iwasaki; Mitsumasa Ohyanagi
Candida parapsilosis endocarditis that emerged 2 years after abdominal surgery.
Heart and vessels 2004;19(3):149-52.
2004: Hiroshi Takaishi; Takahiro Taniguchi; Yoshio Fujioka; Yuichi Ishikawa; Mitsuhiro Yokoyama
Impact of increasing diabetes on coronary artery disease in the past decade.
Journal of atherosclerosis and thrombosis 2004;11(5):271-7.
2003: Koji Domoto; Takahiro Taniguchi; Hiroshi Takaishi; Tomosaburo Takahashi; Yoshio Fujioka; Akihiro Takahashi; Yuichi Ishikawa; Mitsuhiro Yokoyama
Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells.
Atherosclerosis 2003;171(2):193-200.
2003: Yoshiro Naito; Takeshi Tsujino; Daizo Kawasaki; Takahiro Okumura; Shinji Morimoto; Miho Masai; Tsuyoshi Sakoda; Yoshio Fujioka; Mitsumasa Ohyanagi; Tadaaki Iwasaki
Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats.
Journal of hypertension 2003;21(6):1107-15.
2003: Daizo Kawasaki; Takeshi Tsujino; Shinji Morimoto; Yoshio Fujioka; Yoshiro Naito; Takahiro Okumura; Motomaru Masutani; Hiroki Shimizu; Masao Yuba; Atsunori Ueda; Mitsumasa Ohyanagi; Shin-ichiro Kashiwamura; Haruki Okamura; Tadaaki Iwasaki
Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty.
The American journal of cardiology 2003;91(10):1258-61.
2003: Shinji Morimoto; Yoshio Fujioka; Hiroshi Hosoai; Takahiro Okumura; Miho Masai; Tsuyoshi Sakoda; Takeshi Tsujino; Mitsumasa Ohyanagi; Tadaaki Iwasaki
The renin-angiotensin system is involved in the production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants.
Hypertension research : official journal of the Japanese Society of Hypertension 2003;26(4):315-23.
2003: Jong Il Kim; Takeshi Tsujino; Yoshio Fujioka; Komei Saito; Mitsuhiro Yokoyama
Bezafibrate improves hypertension and insulin sensitivity in humans.
Hypertension research : official journal of the Japanese Society of Hypertension 2003;26(4):307-13.
2003: Yoshio Fujioka; Miho Masai; Sayaka Tsuboi; Takahiro Okumura; Shinji Morimoto; Takeshi Tsujino; Mitsumasa Ohyanagi; Tadaaki Iwasaki
Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension 2003;26(1):111-6.
2002: Yoshiro Naito; Takeshi Tsujino; Yoshio Fujioka; Mitsumasa Ohyanagi; Tadaaki Iwasaki
Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats.
Hypertension 2002;40(6):827-33.
2002: Takahiro Okumura; Yoshio Fujioka; Shinji Morimoto; Sayaka Tsuboi; Miho Masai; Takeshi Tsujino; Mitsumasa Ohyanagi; Tadaaki Iwasaki
Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability.
The American journal of the medical sciences 2002;324(5):247-53.
2000: Yoshio Fujioka; Takahiro Taniguchi; Yoshihiro Ishikawa; Mitsuhiro Yokoyama
Significance of acidic sugar chains of apolipoprotein B-100 in cellular metabolism of low-density lipoproteins.
The Journal of laboratory and clinical medicine 2000;136(5):355-62.
2000: K Matsumoto; Takahiro Taniguchi; Yoshio Fujioka; H Shimizu; Yoshihiro Ishikawa; Mitsuhiro Yokoyama
Effects of hypoxia on cholesterol metabolism in human monocyte-derived macrophages.
Life sciences 2000;67(17):2083-91.
2000: A Nobusawa; Takahiro Taniguchi; Yoshio Fujioka; H Inoue; H Shimizu; Yoshihiro Ishikawa; Mitsuhiro Yokoyama
Glibenclamide inhibits accumulation of cholesteryl ester in THP-1 human macrophages.
Journal of cardiovascular pharmacology 2000;36(1):101-8.
2000: S Kawasaki; Takahiro Taniguchi; Yoshio Fujioka; Akihiro Takahashi; Tomosaburo Takahashi; Koji Domoto; M Taguchi; Yoshihiro Ishikawa; Mitsuhiro Yokoyama
Chylomicron remnant induces apoptosis in vascular endothelial cells.
Annals of the New York Academy of Sciences 2000;902():336-41.